Focused ultrasound (FUS) is a disruptive medical technology, and its implementation in the
clinic represents the culmination of decades of research. Lying at the convergence of …

Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in
novel ways of approaching diagnostic and therapeutic techniques beyond what is possible …

The paper reports the results of nanotherapy of ovarian, breast, and pancreatic cancerous
tumors by paclitaxel-loaded nanoemulsions that convert into microbubbles locally in tumor …

Purpose: High‐resolution vascular imaging has not been achieved in the brain due to
limitations of current clinical imaging modalities. The authors present a method for …

Currently available microbubbles used for ultrasound imaging and therapeutics are limited
to intravascular space due to their size distribution in the micron range. Phase-change …

Focused ultrasound offers a non-invasive way of depositing acoustic energy deep into the
body, which can be harnessed for a broad spectrum of therapeutic purposes, including …

The vaporization of a superheated droplet emulsion into gas bubbles using ultrasound-
termed acoustic droplet vaporization (ADV)-has potential therapeutic applications in …

During the past decade, ultrasound has expanded medical imaging well beyond the
“traditional” radiology setting: a combination of portability, low cost, and ease of use makes …

Many studies have explored phase-change contrast agents (PCCAs) that can be vaporized
by an ultrasonic pulse to form microbubbles for ultrasound imaging and therapy. However …

The development of phased array transducers and their integration with magnetic
resonance (MR) guidance and thermal monitoring has established transcranial MR-guided …